drug
miltefosine
Marketedupdated 3mo agoby Profounda Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying miltefosine
- phase2A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
- —Treatment of Leishmaniasis With Impavido® (Miltefosine): Pregnancy Registry
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that